Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. DaratumuMAb+>1

---

USA. J. DaratumuMAb+>1's subsections
(*) USA Approval Date: 2016. 11.
+Lenalidomide or Bortezomib+Dexamet
>Prior Line of Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 12.24.
RTM
RTM Web-Site

USA. J. DaratumuMAb+>1's products
This section has no products